ADA Scientific Sessions 2026 Abstract

Discovery of Selective, Long-Acting Amylin Receptor Agonist for Obesity

By Spring Zhao, Xiao Jin, Gang Chen, Keke Hu

Experiments in animalsInterventions

The paper

Spring Zhao, Xiao Jin, Gang Chen, Keke Hu

Suzhou

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1664-P

doi.org/10.2337/db26-1664-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes